ethyl 3-(2-hydroxyethyl)-5-methyl-2,4-dioxo-1-(2-phenylethyl)thieno[2,3-d]pyrimidine-6-carboxylate

ID: ALA4476176

PubChem CID: 8072533

Max Phase: Preclinical

Molecular Formula: C20H22N2O5S

Molecular Weight: 402.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1sc2c(c1C)c(=O)n(CCO)c(=O)n2CCc1ccccc1

Standard InChI:  InChI=1S/C20H22N2O5S/c1-3-27-19(25)16-13(2)15-17(24)21(11-12-23)20(26)22(18(15)28-16)10-9-14-7-5-4-6-8-14/h4-8,23H,3,9-12H2,1-2H3

Standard InChI Key:  QYWCWTDAWUBHFE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   27.4709  -14.3845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1787  -13.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8905  -14.3845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8905  -15.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1787  -15.6152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4709  -15.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6926  -15.4578    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.2114  -14.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6927  -14.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4808  -13.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3927  -14.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9853  -15.5034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.9853  -14.0886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1666  -14.0886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7593  -13.3770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1787  -16.4340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8902  -16.8413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8902  -17.6600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5976  -18.0676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5965  -18.8828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8887  -19.2944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1811  -18.8878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1784  -18.0698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5980  -15.6150    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.5980  -13.9772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3054  -14.3845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0128  -13.9772    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.1787  -13.1583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  1  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  1  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
  5 16  1  0
 16 17  1  0
 17 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 18 23  1  0
  4 24  2  0
  3 25  1  0
 25 26  1  0
 26 27  1  0
  2 28  2  0
M  END

Associated Targets(Human)

ACACA Tchem Acetyl-CoA carboxylase 1 (794 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACACB Tchem Acetyl-CoA carboxylase 2 (3474 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.47Molecular Weight (Monoisotopic): 402.1249AlogP: 1.94#Rotatable Bonds: 7
Polar Surface Area: 90.53Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.11CX LogD: 3.11
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -1.41

References

1. Romero FA, Jones CT, Xu Y, Fenaux M, Halcomb RL..  (2020)  The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.,  63  (10): [PMID:31930920] [10.1021/acs.jmedchem.9b01701]

Source